#BREAKINGNEWS: The FDA has granted Priority Review of our #ADC for the treatment of certain patients with metastatic #BreastCancer. Click the image for more information on the filing and what it may mean for patients impacted by these cancers.
Daiichi Sankyo US
Pharmaceutical Manufacturing
Basking Ridge, NJ 193,485 followers
We create life-changing solutions for patients.
About us
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/4fLkZS8
- Website
-
https://daiichisankyo.us/
External link for Daiichi Sankyo US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Basking Ridge, NJ
- Type
- Public Company
- Specialties
- Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines., Oncology, and Specialty Medicine
Locations
-
Primary
211 Mt. Airy Road Basking Ridge
Basking Ridge, NJ 07920, US
Employees at Daiichi Sankyo US
-
Jak (J. C.) DeTemple
Top Talent Executive Recruiter to the Biotech/Pharma Industry Leadership Superstars! Top Talent Sourcing Guru! Talent Acquisition & Retention…
-
Hayes Williams
Global Head of Data Governance at Daiichi Sankyo, Inc.
-
Desmon Swanston
-
Joseph Prikazsky
Pharma/Biotech Financial Professional
Updates
-
By embracing the diversity within our team, we unlock new perspectives that help us better serve patients worldwide. At Daiichi Sankyo US, celebrating Hispanic Heritage Month means recognizing the diversity within Hispanic and Latin cultures and each of our unique lived experiences. For Amanda Hudson, Digital Communications Manager, her Puerto Rican identity is a source of pride, reminding us that there’s no single way to be Latina. “Being a good ally means checking your assumptions. Someone might not look Latin or have a Latin sounding name, but that doesn’t detract from who they are. I am a proud Boricua, and I am absolutely Boricua enough." 🔗Click for more on how we champion inclusion: https://lnkd.in/eczSwS_s #DSProud #HispanicHeritageMonth #Inclusion #Belonging
-
We’re pushing the boundaries of research to find new biomarker targets. Why? It's our mission to continuously innovate and find solutions that meet individuals' unique needs, ensuring the best possible outcomes. Discover how biomarker testing personalizes treatment and why advancing awareness of this critical component of cancer screening is essential: https://bit.ly/4dDH4jC
-
Breast cancer accounts for 30% of all cancer diagnoses in women each year in the United States. 🔗 Discover how we amplify the efforts of our partners—like The Breasties, Living Beyond Breast Cancer, Unite for HER, and Young Survival Coalition — to ensure that everyone impacted by #BreastCancer feels seen, heard, and most importantly, supported: https://bit.ly/4d2IJiX #BreastCancerAwarenessMonth
-
At Daiichi Sankyo, Compassion for Innovation and Compassion for Patients™ is more than a tagline – it’s at the core of everything we do. Watch how these two elements converge in the latest episode, “Where Craft Meets – Patients.” Our Global Head of Advocacy & Strategic Relations Gissoo DeCotiis explores the critical role of translating science into a “language patients not only understand but can then feel empowered to utilize to become more engaged in their care and treatment plans.” Join us exclusively on the Daiichi Sankyo US YouTube channel as one of our R&D leaders, Dalila Sellami brings Gissoo’s craft of Translation to life. https://bit.ly/4efbmdl #WhereCraftMeets #oncology #cancer #innovation #PatientAdvocacy
-
💼⚾️From fielding ground balls to finding common ground, baseball bridges the gap. For 20+ years, the Daiichi Sankyo Rising Suns baseball team has competed in the “Nippon Club President’s Cup” Annual Baseball Tournament helping to build connections and trust between our Japanese ex-pats working in the US and local colleagues through love of the sport. 📅 As the regular baseball season comes to a close, we celebrate our Rising Suns and their shining example of teamwork and camaraderie! 🌞 #DSProud #culture #baseball
-
At Daiichi Sankyo, we have 1 Purpose: to enrich quality of life using groundbreaking technology. Watch our video on the experts who developed our proprietary ADCs and the challenges they overcame through innovation: https://bit.ly/3BjHMF9
-
When we welcome, respect, and empower more voices, we make a powerful difference for our employees and for the patients we strive to help. To Valerie Kuehner, Benefits Manager, celebrating Hispanic Heritage Month is an opportunity to share her Puerto Rican culture with others and cultivate a deeper appreciation for diversity “I am proud of my Hispanic heritage. Being a Latina in the U.S., I've made it my mission to share my experiences and culture with others. I strongly believe exposing people to other cultures will lead them to appreciate the value of diversity and help build inclusive communities.” At Daiichi Sankyo US, our commitment to inclusion and diversity is something we live each day—it’s essential to how we innovate and serve our patients. 🔗Click for more on how we thrive together: https://lnkd.in/eczSwS_s #DSProud #HispanicHeritageMonth #Inclusion #Belonging
-
As we close out the International Advertising Association World Congress 2024 for the Study of Lung Cancer and the ESMO - European Society for Medical Oncology congresses we reflect on the larger purpose of these meetings – to challenge the status quo by collectively sharing the latest clinical advances in oncology in the pursuit of helping as many people as possible impacted by cancer. It was a privilege to share more than 25 abstracts at #WCLC24 and #ESMO24. The full breadth of our data reaffirms our commitment to creating better futures through medicine for patients with cancer and emphasizes the comprehensive scope of our ADC portfolio spanning multiple cancer types. #WCLC24 #ESMO24 #OncologyResearch
-
Making the broadest possible impact on patients’ lives—that's what drives Dalila Sellami, M.D., Vice President, Global Team Leader, Oncology Research & Development, at Daiichi Sankyo US. 🗺 Her remarkable journey traverses three continents and grows from being the first female radiation oncologist in her native Tunisia to leading the global team behind our promising oncology pipeline. 🔗 Read on: https://bit.ly/4dDcQxZ #DSProud #WPSD2024 #PatientSafety